We also calculated no statistically significant difference in the average percentages of cells that stained positively for SULF2 in tissue sections of TNBC, ER+/PR+ breast cancer, and HER2+ breast cancer (Figure 5c). This evidence concerns the gene SULF2 and breast carcinoma.